BRIEF: BenQ BM tumbles in Hong Kong trading debut
Private hospital operator BenQ BM Holding Cayman Corp. (2581.HK) opened 30.4% lower in its Hong Kong trading debut on Monday, and continued to slide to close down 42.29% at HK$5.39…
BRIEF: Leading RNA drug developer Ribo passes Hong Kong listing hearing, kicking off IPO
Leading RNA drug developer Suzhou Ribo Life Science Co. Ltd. passed its hearing for a listing on the Hong Kong Stock Exchange, marking the official launch of its IPO, according…
BRIEF: Bao Pharma doubles in Hong Kong trading debut
Shares Shanghai Bao Pharmaceuticals Co. Ltd. (2659.HK) opened up 128% in their Hong Kong trading debut on Wednesday, and held on to the gains during the morning session to close…
BRIEF: InSilico gets CSRC nod for Hong Kong IPO
AI drug discovery platform InSilico Medicine Cayman TopCo has been approved by China’s securities watchdog for a Hong Kong IPO, clearing a key hurdle in its stalled listing. According to…
INDUSTRY BRIEF: Healthcare stocks under pressure as national drug list expands
Many Hong Kong-listed drugmakers on Monday announced their products that were included in the 2025 edition of China’s National Reimbursement Drug List (NRDL), which was unveiled this week. The updated…
BRIEF: Bao Pharma launches $128 million Hong Kong IPO
Shanghai Bao Pharma Co. Ltd. (2659.HK) launched its Hong Kong IPO on Tuesday, planning to sell 37.9 million shares at an offer price of HK$26.38 per share, raising up to…
BRIEF: Wai Yuen Tong’s profit plunges in first half of fiscal year
Drug and healthcare products maker Wai Yuen Tong Medicine Holdings Ltd. (0897.HK) warned on Monday that it expects to report its profit plunged 87% year-on-year to HK$3 million ($390,000) or…
